NASDAQ:STLN | Debt/Equity Ratio | Starling Oncology, Inc.

Complete source-backed debt/equity ratio history.

Available history
2020-12-31 to 2022-12-31
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2022-12-310.65
2022-09-300.62
2021-12-310
2020-12-310.42

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2022-12-310.65
2021-12-310
2020-12-310.42

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.